Next |
home / stock / mrna / mrna message board
Subject | By | Source | When |
---|---|---|---|
Cathie Wood's ARK Innovation ETF buys shares of | axelvento | investorshub | 05/01/2023 4:39:04 AM |
Believe in what | Vexari | investorshub | 05/01/2023 4:25:38 AM |
the important thing is to believe not to hope! | axelvento | investorshub | 05/01/2023 4:14:06 AM |
The thought of overthinking without explanation | Vexari | investorshub | 04/30/2023 8:03:20 PM |
Without understanding | Vexari | investorshub | 04/29/2023 9:23:49 PM |
Making good personal choices in one's health care regimen | Vexari | investorshub | 04/29/2023 7:58:32 PM |
Germ ~~ virus theory is not a theory | Vexari | investorshub | 04/28/2023 11:38:41 PM |
Covid vaccine maker is sitting on $18bn and | axelvento | investorshub | 04/28/2023 4:18:00 AM |
For my second pick, I'm swinging for the | axelvento | investorshub | 04/28/2023 4:12:39 AM |
I find value in your desperation....over thinking! | axelvento | investorshub | 04/28/2023 3:24:38 AM |
Desperation, is beginning to show itself | Vexari | investorshub | 04/27/2023 10:41:53 PM |
Really | Vexari | investorshub | 04/27/2023 9:59:45 PM |
Florida surgeon general altered Covid-19 vaccine analysis to | axelvento | investorshub | 04/27/2023 4:30:40 AM |
Government involvement | Vexari | investorshub | 04/26/2023 8:31:50 PM |
Construction commences at Moderna Innovation and Technology Centre | axelvento | investorshub | 04/26/2023 11:56:40 AM |
imo...i have millions upon millions of quiet followers | IHuser | investorshub | 04/22/2023 3:12:27 AM |
Bancel's sell program has been consistent. Selling | FooBarAndGrill | investorshub | 04/20/2023 6:15:56 PM |
Moderna and IBM- | axelvento | investorshub | 04/20/2023 12:06:20 PM |
RSV vaccine approval should be a top priority | axelvento | investorshub | 04/20/2023 11:57:24 AM |
They just wanted to drop the price so | Civil War General | investorshub | 04/18/2023 11:08:13 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-26 04:50:00 ET Moderna (NASDAQ: MRNA) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions of dollars in sales. But as demand for the vaccine declined, Moderna stock followed. Investors are worried...
GSK Plc (NYSE:GSK) has reportedly taken legal action against Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) in a...
CAMBRIDGE, MA / ACCESSWIRE / April 25, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data from its respiratory portfolio, including vaccines and vaccine candidates against COVID-19 (mRNA-1273, mRNA-1283), influenza (mRNA-1010, mRNA-1011/1012), and respiratory s...